PlainRecalls
FDA Drug Moderate Class II Terminated

Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc

Reported: May 16, 2018 Initiated: April 24, 2018 #D-0733-2018

Product Description

Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc

Reason for Recall

Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Details

Recalling Firm
Vitalab Pharmacy, Inc
Units Affected
60 vials
Distribution
The recalled product was distributed to patients throughout the United States.
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL, Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc. Recalled by Vitalab Pharmacy, Inc. Units affected: 60 vials.
Why was this product recalled?
Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 16, 2018. Severity: Moderate. Recall number: D-0733-2018.